1) Global incidence for HCC, 2018:
What is the global incidence of hepatocellular carcinoma (HCC) worldwide? (Medscape, 2019):
Worldwide, liver cancer was the fifth most common cancer and the third
most common cause of cancer deaths in 2018, with an estimated 841,080
new cases and 781,631 deaths. The incidence was highest in East Asia,
at 17.7 per 100,000 population (26.8 in males and 8.7 in females),
followed by Micronesia, northern Africa, Southeast Asia, and
Melanesia. The incidence was lowest in south-central Asia (2.5 per
100,000) and western Asia (4.0 per 100,000). By comparison, the
incidence rate was 6.6 per 100,00 in North America and 5.3 per 100,000
in western Europe. Overall, the incidence rate of liver cancer is
approximately three times higher in males than in females. Mortality
figures mirror the incidence figures.
2) Global incidence, prevalence and mortality for HCC, 2018: Hepatocellular carcinoma, The New England Journal of Medicine, 2019):
Figure 1 shows a worldwide map of incidence, prevalence and mortality of HCC per 100,000 population in 2018.
3) 1-year global prevalence of liver cancer, 2018: Worldwide data by country from Global Cancer Observatory, 2018: a map and a table.